Priyanka Bharti

Ms. Priyanka Bharti


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2022 in Cancers
Verified
Journal Article
Open access
PDF file
AOAnupama Ojha
Anupama Ojha
SJSonali Jaiswal
Sonali Jaiswal
PBPriyanka Bharti
Priyanka Bharti
SMSarad Kumar Mishra
Sarad Kumar Mishra
Along with the extensive improvement in tumor biology research and different therapeutic developments, cancer remains a dominant and deadly disease. Tumor heterogeneity, systemic toxicities, and drug resistance are major hurdles in cancer therapy. Chemotherapy, radiotherapy, phototherapy, and surgical therapy are some prominent areas of cancer treatment. During chemotherapy for cancer, chemotherapeutic agents are distributed all over the body and also damage normal cells. With advancements in nanotechnology, nanoparticles utilized in all major areas of cancer therapy offer the probability to advance drug solubility, and stability, extend drug half-lives in plasma, reduce off-target effects, and quintessence drugs at a target site. The present review compiles the use of different types of nanoparticles in frequently and recently applied therapeutics of cancer therapy. A recent area of cancer treatment includes cancer stem cell therapy, DNA/RNA-based immunomodulation therapy, alteration of the microenvironment, and cell membrane-mediated biomimetic approach. Biocompatibility and bioaccumulation of nanoparticles is the major impediment in nano-based therapy. More research is required to develop the next generation of nanotherapeutics with the incorporation of new molecular entities, such as kinase inhibitors, siRNA, mRNA, and gene editing. We assume that nanotherapeutics will dramatically improve patient survival, move the model of cancer treatment, and develop certainty in the foreseeable future.

12 April 2024 in Proceedings
Verified
Conference Paper
Open access
PDF file
Praveen Kumar MaddheshiyaPraveen Kumar Maddheshiya
Praveen Kumar Maddheshiya
PBPriyanka Bharti
Priyanka Bharti
SMSarad Kumar Mishra
Sarad Kumar Mishra
KGKapil Gupta
Kapil Gupta
Mercury (Hg) is a highly toxic heavy metal that causes significant risks to human health and the environment. This study explores the sources and routes of mercury exposure to humans, its toxicological effects, and the various methods of phytoremediation and bioremediation to mitigate (Reduce) mercury contamination in the environment. Mercury exposure to humans primarily occurs through the consumption of contaminated seafood, the inhalation of mercury vapour, and occupational exposure, which can lead to adverse health effects, including neurological disorders, cardiovascular issues, and developmental defects. Furthermore, mercury contamination in the environment can persist and bioaccumulate in the food chain, further exacerbating the risks to human health. Phytoremediation, a sustainable and cost-effective method, involves the use of plants to extract, stabilize, or transform mercury in contaminated soils or water. Various plant species have demonstrated the ability to accumulate and detoxify mercury through mechanisms such as phytochelation and rhizofiltration. Additionally, the genetic engineering of plants can be achieved to enhance mercury uptake, and accumulation is also a promising method used for efficient phytoremediation. Bioremediation, on the other hand, involves the use of microorganisms, such as bacteria and fungi, to remediate mercury-contaminated sites. These microorganisms can reduce mercury to less toxic forms (e.g., elemental mercury to less soluble mercuric ions) or form complexes that immobilize mercury. Apart from microbes and plants, seaweed or seaweed-derived products can be seen as an efficient alternative for the bioaccumulation of mercury. Bioremediation techniques are being continuously developed and optimized to enhance their efficiency and applicability.